Core Insights - Eagle Eye Technology-B (02251) reported a mid-term performance for the six months ending June 30, 2025, with revenue of 83.713 million RMB, a gross profit of 64.103 million RMB, and a net profit of 0.443 million RMB, marking a turnaround from a loss of 81.488 million RMB in the same period last year [1] Group 1: Financial Performance - Revenue for the reporting period was 83.713 million RMB, with a gross profit of 64.103 million RMB, reflecting a year-on-year increase of 13.53% [1] - The company achieved a net profit of 0.443 million RMB, compared to a loss of 81.488 million RMB in the previous year, indicating a significant turnaround [1] Group 2: Product and Service Expansion - The number of active service points for the retinal detection AI products increased from 5,950 to 7,180, representing a year-on-year growth of 20.7% [1] - The usage of myopia prevention AI products reached 2.812 million times, a year-on-year increase of 68.1%, with the company establishing a distribution service system and star store service system for the PBM-LED myopia treatment device [1] - The visual training AI products recorded 1.026 million training sessions, showing a year-on-year growth of 11.6% [1] Group 3: New Product Development - The company successfully developed and launched a new generation of physiological stress capacity detection product, the "Eagle Eye Stress Capacity Detector," based on wireless sensing technology and multimodal AI algorithms, which has completed product finalization and market testing [1]

Financial Performance - The company reported a revenue of 83.713 million RMB for the six months ending June 30, 2025, with a gross profit of 64.103 million RMB, representing a year-on-year increase of 13.53% [1] - The net profit for the period was 0.443 million RMB, a significant turnaround from a loss of 81.488 million RMB in the same period last year [1] Product and Service Expansion - The number of active service points for the retinal detection AI products increased from 5,950 to 7,180, marking a year-on-year growth of 20.7% [1] - The company detected 3.3 million cases through SaMD and health risk assessment solutions, reflecting an 11.4% year-on-year increase [1] - The usage of myopia prevention AI products reached 2.812 million times, a substantial growth of 68.1% year-on-year [1] - The visual training AI products recorded 1.026 million training sessions, which is an 11.6% increase compared to the previous year [1] New Product Development - The company successfully developed and launched a new generation of physiological stress capacity detection product, the "Eagle Eye Stress Capacity Detector," based on wireless sensing technology and multimodal AI algorithms, which has completed product finalization and market testing [2]